Latest Innovation News

Ionic Rare Earths has signed a pivotal MOU with EMR to develop a circular supply chain for rare earth magnets, supporting its Belfast recycling plant and the UK’s net-zero ambitions.

Rhythm Biosciences has successfully validated its second-generation ColoSTAT® Beta assay, confirming its readiness for commercial application in colorectal cancer detection. The Beta kit offers improved precision and faster turnaround times compared to its predecessor.

Way2VAT unveils a bold growth strategy leveraging patented AI technology to dominate the expanding digital tax processing market, targeting rapid profitability in 2025. The company’s unified SaaS platform integrates VAT reclaim, real-time invoice validation, compliance services, and e-invoicing across 40+ countries.

Way2VAT has secured a significant three-year contract with global real estate giant JLL, deploying its AI-driven VAT recovery and compliance platform across 25 entities worldwide. This deal positions Way2VAT as a key player in automated VAT solutions for multinational corporations.

WiseTech Global has announced its acquisition of E2open Parent Holdings, Inc. for $2.1 billion, significantly broadening its footprint in global trade and logistics software. The deal is expected to accelerate WiseTech’s vision of becoming the operating system for global trade and logistics.

WiseTech Global has announced a $2.1 billion acquisition of US-based e2open, aiming to create a comprehensive global trade and logistics marketplace. The deal, fully debt-funded and expected to close in the first half of 2026, promises to expand WiseTech’s product suite, customer base, and market reach.

The Calmer Co. International Limited has significantly expanded the distribution of its flagship kava products in Coles supermarkets, reflecting growing consumer appetite for natural relaxation alternatives to alcohol.

MLG Oz Limited has secured its first contract with mining giant Rio Tinto, marking a significant expansion into the Pilbara region with a $20 million haulage and site services deal.

Immutep’s novel immunotherapy combination with radiotherapy and KEYTRUDA® has met its primary endpoint in a Phase II trial for resectable soft tissue sarcoma, showing promising early signs of improved patient outcomes.

Proteomics International has validated its PromarkerEndo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis, with commercial launch planned in Australia for Q3 2025. The test promises to reduce the average seven-year diagnostic delay by providing a simple risk score applicable across all disease stages.

EROAD Limited reported solid financial results for FY25, with revenue up 6.8% to NZ$194.4 million and a substantial improvement in free cash flow to NZ$16 million. The company’s strategic focus on enterprise fleet growth and innovation underpins a confident FY26 guidance.

GreenHy2 Limited has broadened its renewable energy storage portfolio by integrating graphene-based hybrid supercapacitor batteries, reporting robust FY24 growth and advancing key customer trials.